Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Articles
BioCentury
|
Jul 5, 2010
Company News
ProStrakan, Uluru, Crawford Pharmaceuticals deal
...be split equally between the partners. Uluru gained the antibiotic through last year's acquisition of
York Pharma plc
...
Read More
BioCentury
|
Oct 19, 2009
Finance
Ebb & Flow
...fiscal year ended June 30. Solvay had planned to sell the products last year to
York Pharma plc
...
Read More
BioCentury
|
Aug 3, 2009
Company News
York Pharma dermatology news
...£28.6 million ($47 million) through the sale of debt and equity (see BioCentury, July 6).
York Pharma plc
...
Read More
BioCentury
|
Jul 6, 2009
Company News
Uluru, York Pharma deal
...the company had a 12-month operating loss of $10.1 million. Uluru Inc. (NYSE-A:ULU), Addison, Texas
York Pharma plc
...
Read More
BioCentury
|
Jul 6, 2009
Company News
York Pharma management update
York Pharma plc
(LSE:YRK), Milton Keynes, U.K. Business: Dermatology Departing: Terry Sadler, founder and president WIR Staff Dermatology...
Read More
BioCentury
|
Apr 13, 2009
Company News
Uluru, York Pharma deal
...million ($56.6 million) (see BioCentury, Jan. 26, & April 6). Uluru Inc. (NYSE-A:ULU), Addison, Texas
York Pharma plc
...
Read More
BioCentury
|
Apr 6, 2009
Company News
York Pharma dermatology news
...since raised at least £28.6 million ($56.6 million) (see BioCentury, Jan. 26 and Feb. 9).
York Pharma plc
...
Read More
BioCentury
|
Feb 9, 2009
Company News
York Pharma dermatology news
...The company has since raised at least £28.6 million ($56.6 million) (see BioCentury, Jan. 26).
York Pharma plc
...
Read More
BioCentury
|
Jan 26, 2009
Company News
York Pharma, Solvay deal
...raised at least £28.6 million ($56.6 million), excluding the £14.4 million loan facility with Fortress.
York Pharma plc
...
Read More
BioCentury
|
Jan 5, 2009
Company News
Sinclair, York Pharma sales and marketing update
...plc (LSE:PSK, Galashiels, U.K.) (see BioCentury, Oct. 15, 2007). Sinclair Pharma plc (LSE:SPH), Godalming, U.K.
York Pharma plc
...
Read More
Items per page:
10
1 - 10 of 34
BioCentury
|
Jul 5, 2010
Company News
ProStrakan, Uluru, Crawford Pharmaceuticals deal
...be split equally between the partners. Uluru gained the antibiotic through last year's acquisition of
York Pharma plc
...
Read More
BioCentury
|
Oct 19, 2009
Finance
Ebb & Flow
...fiscal year ended June 30. Solvay had planned to sell the products last year to
York Pharma plc
...
Read More
BioCentury
|
Aug 3, 2009
Company News
York Pharma dermatology news
...£28.6 million ($47 million) through the sale of debt and equity (see BioCentury, July 6).
York Pharma plc
...
Read More
BioCentury
|
Jul 6, 2009
Company News
Uluru, York Pharma deal
...the company had a 12-month operating loss of $10.1 million. Uluru Inc. (NYSE-A:ULU), Addison, Texas
York Pharma plc
...
Read More
BioCentury
|
Jul 6, 2009
Company News
York Pharma management update
York Pharma plc
(LSE:YRK), Milton Keynes, U.K. Business: Dermatology Departing: Terry Sadler, founder and president WIR Staff Dermatology...
Read More
BioCentury
|
Apr 13, 2009
Company News
Uluru, York Pharma deal
...million ($56.6 million) (see BioCentury, Jan. 26, & April 6). Uluru Inc. (NYSE-A:ULU), Addison, Texas
York Pharma plc
...
Read More
BioCentury
|
Apr 6, 2009
Company News
York Pharma dermatology news
...since raised at least £28.6 million ($56.6 million) (see BioCentury, Jan. 26 and Feb. 9).
York Pharma plc
...
Read More
BioCentury
|
Feb 9, 2009
Company News
York Pharma dermatology news
...The company has since raised at least £28.6 million ($56.6 million) (see BioCentury, Jan. 26).
York Pharma plc
...
Read More
BioCentury
|
Jan 26, 2009
Company News
York Pharma, Solvay deal
...raised at least £28.6 million ($56.6 million), excluding the £14.4 million loan facility with Fortress.
York Pharma plc
...
Read More
BioCentury
|
Jan 5, 2009
Company News
Sinclair, York Pharma sales and marketing update
...plc (LSE:PSK, Galashiels, U.K.) (see BioCentury, Oct. 15, 2007). Sinclair Pharma plc (LSE:SPH), Godalming, U.K.
York Pharma plc
...
Read More
Items per page:
10
1 - 10 of 34
Previous page
Next page